rs201777848
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_021926.4(ALX4):c.314_325delCGCAGCCGCAGC(p.Pro105_Gln108del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00455 in 1,555,108 control chromosomes in the GnomAD database, including 274 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.025 ( 156 hom., cov: 33)
Exomes 𝑓: 0.0024 ( 118 hom. )
Consequence
ALX4
NM_021926.4 disruptive_inframe_deletion
NM_021926.4 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.41
Genes affected
ALX4 (HGNC:450): (ALX homeobox 4) This gene encodes a paired-like homeodomain transcription factor expressed in the mesenchyme of developing bones, limbs, hair, teeth, and mammary tissue. Mutations in this gene cause parietal foramina 2 (PFM2); an autosomal dominant disease characterized by deficient ossification of the parietal bones. Mutations in this gene also cause a form of frontonasal dysplasia with alopecia and hypogonadism; suggesting a role for this gene in craniofacial development, mesenchymal-epithelial communication, and hair follicle development. Deletion of a segment of chromosome 11 containing this gene, del(11)(p11p12), causes Potocki-Shaffer syndrome (PSS); a syndrome characterized by craniofacial anomalies, cognitive disability, multiple exostoses, and genital abnormalities in males. In mouse, this gene has been shown to use dual translation initiation sites located 16 codons apart. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 11-44309737-TGCTGCGGCTGCG-T is Benign according to our data. Variant chr11-44309737-TGCTGCGGCTGCG-T is described in ClinVar as [Benign]. Clinvar id is 776604.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0846 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALX4 | NM_021926.4 | c.314_325delCGCAGCCGCAGC | p.Pro105_Gln108del | disruptive_inframe_deletion | 1/4 | ENST00000652299.1 | NP_068745.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALX4 | ENST00000652299.1 | c.314_325delCGCAGCCGCAGC | p.Pro105_Gln108del | disruptive_inframe_deletion | 1/4 | NM_021926.4 | ENSP00000498217.1 |
Frequencies
GnomAD3 genomes AF: 0.0248 AC: 3765AN: 151820Hom.: 156 Cov.: 33
GnomAD3 genomes
AF:
AC:
3765
AN:
151820
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00498 AC: 778AN: 156232Hom.: 29 AF XY: 0.00425 AC XY: 364AN XY: 85612
GnomAD3 exomes
AF:
AC:
778
AN:
156232
Hom.:
AF XY:
AC XY:
364
AN XY:
85612
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00235 AC: 3298AN: 1403174Hom.: 118 AF XY: 0.00206 AC XY: 1428AN XY: 693132
GnomAD4 exome
AF:
AC:
3298
AN:
1403174
Hom.:
AF XY:
AC XY:
1428
AN XY:
693132
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0248 AC: 3771AN: 151934Hom.: 156 Cov.: 33 AF XY: 0.0247 AC XY: 1831AN XY: 74270
GnomAD4 genome
AF:
AC:
3771
AN:
151934
Hom.:
Cov.:
33
AF XY:
AC XY:
1831
AN XY:
74270
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 16, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at